Is Scienture Holdings Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Scienture Holdings Inc (SCNX) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Scienture Holdings Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Scienture Holdings Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Scienture Holdings Inc?

Muslim investors may consider investing in Scienture Holdings Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Scienture Holdings Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Scienture Holdings Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Scienture Holdings Inc updated?

The Shariah compliance status of Scienture Holdings Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Scienture Holdings Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Scienture Holdings Inc?

You can check the latest Shariah compliance status of Scienture Holdings Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

SCNX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 01, 2026

Report Source: 2025 Annual Report

Scienture Holdings Inc. Stock Analysis SCNX

United States Health Care Nano Cap Report: 2025 Annual

Scienture Holdings, Inc. engages in the provision of health services and pharmaceutical products. The company is headquartered in Commack, New York and currently employs 4 full-time employees. The company went IPO on 2020-02-18. Scienture, LLC is focused on developing and commercializing products for the treatment of central nervous system and cardiovascular diseases. Scienture LLC is developing a range of product candidates, including new potential treatments for hypertension, migraine, pain and thrombosis and other related disorders. The firm's product candidates include SCN- 102 (hypertension), SCN- 104 (CNS-Pain), SCN- 106 (Cardiovascular) and SCN- 107 (Pain). SCN-102 is an oral liquid formulation of losartan potassium in development for the treatment of hypertension. SCN-104 is a multi-dose pen-based delivery system for self-injection and increased patient convenience, which is in development for the acute treatment of migraine headaches.

Key Statistics of Scienture Holdings Inc (SCNX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.40$0.44

Today's Open

$0.41

Volume

322.31K

P/E Ratio (TTM)

52 Week Range

$0.24$2.60

Market Cap

15.87M

Avg. Volume

472.08K

Dividend Yield

13.17%

Financial Metrics & Statements of Scienture Holdings Inc (SCNX)

FAQ's for Scienture Holdings Inc (SCNX)

According to Musaffa’s Shariah screening methodology, Scienture Holdings Inc (SCNX) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.